Boehringer Ingelheim has appointed Meenal Gauri as Managing Director, India, effective 12 January 2026. In her new role, she will oversee the company’s operations across India, Bangladesh, Nepal, Sri Lanka and Maldives. She will also join the Board of Boehringer Ingelheim India.
Meenal brings over 16 years of international experience across Europe, Asia and the Middle East. Her expertise spans marketing, sales, corporate strategy, business development and market access. During her tenure in regional roles with Boehringer Ingelheim, she played a key role in strengthening the company’s presence across complex markets and led several high-impact product launches and strategic initiatives.
Her leadership experience and understanding of diverse healthcare ecosystems are expected to support the company’s India Vision 2030 growth ambitions and patient-focused priorities. In addition to her business leadership background, she is a trained Co-Active coach and has been actively involved in leadership development initiatives.
Reflecting on her appointment, Meenal Gauri said, “My journey at Boehringer Ingelheim has been both inspiring and purposeful. Since my first role here, I’ve experienced significant growth, shaped by diverse interactions with remarkable individuals across geographies and the healthcare community. India continues to be a fascinating and dynamic market, and I remain deeply committed to enhancing patient health across the country. I look forward to collaborating with our teams and partners to deliver impactful innovations that truly make a difference.”
Commenting on the appointment, Evren Ozlu, Head of Human Pharma, India, Middle East, Turkey and Africa (IMETA), said, “Meenal brings deep industry expertise with a people-first approach that reflects our company’s values. We are confident that under her leadership, our India business will continue to advance innovation, strengthen partnerships, and make a positive impact on patients and communities.”
